
M Ventures is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘ KGaA, Darmstadt, Germany's core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. M Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck KGaA, Darmstadt, Germany's science and technology base.
Location:Netherlands, North Holland, Amsterdam
Member count:11-50
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
News 51
Date | Title | Description |
29.01.2022 | Future Fer... | First company to develop an AI... |
11.12.2021 | DNA Script... | DNA Script, a leader in Enzyma... |
11.12.2021 | AI Chip In... | Keith Kressin appointed as new... |
11.12.2021 | Altoida La... | Research collaboration will id... |
11.12.2021 | Merck KGaA... | Merck KGaA, Darmstadt, Germany... |
11.12.2021 | iOmx Thera... | Martinsried / Munich, Germany,... |
11.12.2021 | Altoida Aw... | Breakthrough Designation will ... |
11.12.2021 | DNA Script... | New Funding, Targeted to Accel... |
11.12.2021 | NanoSyrinx... | NanoSyrinx has raised a furthe... |
22.11.2021 | Xilio Ther... | Xilio Therapeutics, Inc. today... |
Show more
Team 23
Date | Name | Description |
18.02.2023 | Leonie Wil... | Leonie Willemse joined the fun... |
16.11.2022 | Tobias Egl... | Tobias Egle, Analyst in the Te... |
13.09.2022 | Oliver Har... | Oliver Hardick, EngD, is Entre... |
22.08.2022 | Ilja Aizen... | Ilja Aizenberg (PhD, MBA) join... |
13.07.2022 | Eyal Ben A... | Eyal Ben Ami, PhD, MBA, joined... |
05.05.2022 | Hakan Goke... | Hakan Goker, PhD, is Managing ... |
05.05.2022 | Owen Lozma... | Dr Owen Lozman FRSC CChem CSci... |
04.02.2022 | Javier Rod... | Javier Rodriguez joined the Ve... |
04.02.2022 | Nadiya Ish... | Nadiya Ishnazarova, PhD, is an... |
04.02.2022 | Daniel Fra... | Daniel Franke, Principal in th... |
Show more
Portfolio 75
Date | Name | Website | Total Raised | Location |
14.04.2023 | ImmuneBrid... | immunebrid... | $12M | United Sta... |
12.03.2023 | Iktos | iktos.ai | $16.618865... | France, Il... |
21.02.2023 | Calypso Bi... | calypsobio... | $55.797665... | Netherland... |
18.02.2023 | Unisers | unisers.ch | $14M | Switzerlan... |
08.11.2022 | Concerto B... | concertobi... | $47.541949... | United Sta... |
08.11.2022 | Hans Scham... | galecto.co... | $154.49846... | Denmark, C... |
08.11.2022 | Immunitas ... | immunitast... | $155M | United Sta... |
08.11.2022 | FoRx Thera... | forxtherap... | $12.111493... | Switzerlan... |
08.11.2022 | Pictor Lab... | pictor-lab... | - | - |
08.11.2022 | Micropsi I... | micropsi-i... | $36.08M | Germany, B... |
Show more
Mentions in press and media 38
Date | Title | Description | Category | Author | Source |
03.05.2023 | Dutch-base... | Leiden-based Anavo Therapeutic... | funding n... | Vishal Sin... | siliconcan... |
09.03.2023 | Iktos rais... | French start-up Iktos has rais... | - | Fiona Alst... | tech.eu/20... |
17.02.2023 | Unisers se... | Particle contamination durin... | Financing | - | startuptic... |
07.07.2022 | Tignis and... | Introductions for Tignis and M... | - | - | einpresswi... |
01.04.2022 | Additional... | Swiss-US company Altoida is ... | Financing | - | startuptic... |
11.02.2022 | Blazing ne... | Berlin-based Micropsi has rais... | - | Dan Taylor | tech.eu/20... |
12.01.2022 | UCLA Spino... | What You Should Know: | - | Syed Hamza... | hitconsult... |
11.12.2021 | Merck KGaA... | Merck KGaA, Darmstadt, Germany... | - | - | m-ventures... |
20.09.2021 | Clinical p... | Calypso Biotech’s lead program... | Financing ... | - | startuptic... |
27.07.2021 | IoT Pionee... | With Softbank’s Vision Fund 2 ... | - | - | africanews... |
Show more